CASTLE BIOSCIENCES, INC. Earnings Per Share (Diluted)
CASTLE BIOSCIENCES, INC. (CSTL) reported Earnings Per Share (Diluted) of -$0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.07, a 146.67% decline year-over-year.
- CASTLE BIOSCIENCES, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.49.
- CASTLE BIOSCIENCES, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.02, a 125.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. earnings per share, diluted for the quarter ending 2025-06-30 was $0.15, a 51.61% decline year-over-year.
- CASTLE BIOSCIENCES, INC. earnings per share, diluted for fiscal 2025 was -$0.83, a 233.87% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. earnings per share, diluted for fiscal 2024 was $0.62.
- CASTLE BIOSCIENCES, INC. earnings per share, diluted for fiscal 2023 was -$2.14.
- CASTLE BIOSCIENCES, INC. earnings per share, diluted for fiscal 2022 was -$2.58.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.07 10-Q · filed 2026-07-30 | -$0.55 10-Q · filed 2026-07-30 | ||
| 2026-03-31 | -$0.49 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | -$0.83 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$0.02 10-Q · filed 2025-11-03 | -$0.76 10-Q · filed 2025-11-03 | ||
| 2025-06-30 | $0.15 10-Q · filed 2026-07-30 | -$0.74 10-Q · filed 2026-07-30 | ||
| 2025-03-31 | -$0.90 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $0.62 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $0.08 10-Q · filed 2025-11-03 | $0.30 10-Q · filed 2025-11-03 | ||
| 2024-06-30 | $0.31 10-Q · filed 2025-08-04 | $0.22 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | -$0.09 10-Q · filed 2025-05-05 | |||
| 2023-12-31 | -$2.14 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$0.26 10-Q · filed 2024-11-04 | -$2.05 10-Q · filed 2024-11-04 | ||
| 2023-06-30 | -$0.70 10-Q · filed 2024-08-05 | -$1.80 10-Q · filed 2024-08-05 | ||
| 2023-03-31 | -$1.10 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$2.58 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$0.77 10-Q · filed 2023-11-02 | -$1.79 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | -$0.06 10-Q · filed 2023-08-02 | -$1.02 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | -$0.97 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | -$1.24 10-K · filed 2023-02-28 | |||
| 2021-09-30 | -$0.47 10-Q · filed 2022-11-02 | -$0.99 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | -$0.35 10-Q · filed 2022-08-08 | -$0.52 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$0.17 10-Q · filed 2022-05-09 | -$0.40 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$0.63 derived: net income ÷ weighted average shares · filed 2022-05-09 | |
| 2020-12-31 | -$0.23 10-K · filed 2021-03-11 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.54 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$0.23 10-Q · filed 2021-11-08 | -$0.29 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$0.08 10-Q · filed 2021-08-09 | -$0.05 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $0.03 10-Q · filed 2021-05-10 | $0.15 derived: net income ÷ weighted average shares · filed 2021-05-10 | $0.20 derived: net income ÷ weighted average shares · filed 2021-05-10 | |
| 2019-12-31 | $0.11 10-K · filed 2021-03-11 | $0.18 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$0.21 10-K · filed 2021-03-11 | |
| 2019-09-30 | $0.05 10-K · filed 2021-03-11 | -$0.67 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$1.05 10-K · filed 2021-03-11 | -$2.26 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | -$1.22 10-K · filed 2021-03-11 | |||
| 2018-12-31 | $0.38 10-K · filed 2020-03-10 | -$0.83 derived: net income ÷ weighted average shares · filed 2020-03-10 | -$5.33 10-K · filed 2020-03-10 | |
| 2018-09-30 | -$2.33 10-K · filed 2020-03-10 | -$6.85 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$2.15 10-K · filed 2020-03-10 | |||
| 2018-03-31 | -$2.37 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |